Bioventus Inc. (BVS): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$184.10M
As of 2025-12-31
$228.31M
As of 2026-06-27
-17.3%
3-year compound annual growth
$458.92M2021-12-31: $458.92M2022-12-31: $325.24M2023-12-31: $173.59M2024-12-31: $147.94M2025-12-31: $184.10M$184.10M
2021-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$184.10M+24.4%2026-03-05, Balance as of period end
2024-12-31$147.94M-14.8%2026-03-05, Balance as of period end
2023-12-31$173.59M-46.6%2025-03-11, Balance as of period end
2022-12-31$325.24Mn/c2024-03-12, Balance as of period end
2021-12-31$458.92Mn/a2023-03-31, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Bioventus Inc. (BVS)2025-12-31$184.10M+24.4%
UFP Technologies Inc (UFPT)2025-12-31$423.88M+23.7%
AtriCure, Inc. (ATRC)2025-12-31$491.94M+6.7%
Glaukos Corp (GKOS)2025-12-31$656.15M-14.4%
NovoCure Ltd (NVCR)2025-12-31$340.47M-5.5%
Artivion, Inc. (AORT)2025-12-31$448.23M+62.3%
iRhythm Holdings, Inc. (IRTC)2025-12-31$152.75M+68.0%
Alphatec Holdings, Inc. (ATEC)2025-12-31$12.43Mn/m
Mimedx Group, Inc. (MDXG)2025-12-31$256.55M+32.9%

Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗